ESICM News

CLINICAL DIAGNOSIS AND TREATMENT OF EBOLA

CLINICAL DIAGNOSIS AND TREATMENT OF EBOLA

An Open Letter to the ICM Community

Dear Colleagues,

Ebola Virus Disease (EVD), also known as Ebola haemorrhagic fever, is caused by one of four classified Ebola viruses. The disease is acute, as its symptoms may start as early as two days after contracting the virus. Beside fever, sore throat, muscle pain, headache, vomiting, diarrhea and rash, patients may require urgent ICU admission for acute liver failure or acute kidney injury. Also, internal and external bleeding can be life threatening. Affected patients face a high rate of fatality - untreated, upwards of 90 percent, 55 percent for those treated in this current outbreak. 

Anyone of us may be facing EVD in our ICU. The disease may spread between people in area with high prevalence, and given globalisation, it could theoretically reach anyone in the community and/or in the ICU.

In order to address this credible threat, this week, ICM is publishing three short papers to help all of us recognise the clinical symptoms of Ebola disease, to heighten continued awareness of the susceptibility of contraction of the disease among critical care specialists, and to provide the basic principles involved in preventing, diagnosing, and managing a suspected or documented case of EVD.

The first article “Does this patient have Ebola Virus Disease?” is online. Two others “Ebola in West Africa; Be aware and prepare” and“Understanding organ dysfunction in Ebola haemorrhagic fever” will be available soon.

We hope that these articles will serve as useful tools to help ensure that this disease will be readily controlled until ongoing research is able to provide a definitive cure for affected patients and a preventive option to avoid new severe cases. 
 
Sincerely,


Élie Azoulay
Editor in Chief, Intensive Care Medicine
<Back to the news list
Comment on this news Comment on this news
To respond to this article, thank you for identifying
ReactionsReactions (0)